These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9527789)

  • 1. Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.
    den Hollander JG; Knudsen JD; Mouton JW; Fuursted K; Frimodt-Møller N; Verbrugh HA; Espersen F
    Antimicrob Agents Chemother; 1998 Feb; 42(2):377-82. PubMed ID: 9527789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
    Kim MK; Zhou W; Tessier PR; Xuan D; Ye M; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3185-92. PubMed ID: 12234843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
    Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
    J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin.
    Novelli A; Fallani S; Cassetta MI; Arrigucci S; Mazzei T
    J Chemother; 2002 Dec; 14(6):584-90. PubMed ID: 12583550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.
    Girard D; Finegan SM; Dunne MW; Lame ME
    J Antimicrob Chemother; 2005 Aug; 56(2):365-71. PubMed ID: 16002421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.
    Knudsen JD; Odenholt I; Erlendsdottir H; Gottfredsson M; Cars O; Frimodt-Møller N; Espersen F; Kristinsson KG; Gudmundsson S
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2499-506. PubMed ID: 12878511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.
    Tissi L; von Hunolstein C; Mosci P; Campanelli C; Bistoni F; Orefici G
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1938-47. PubMed ID: 8540695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic assessment of clarithromycin in a murine model of pneumococcal pneumonia.
    Tessier PR; Kim MK; Zhou W; Xuan D; Li C; Ye M; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2002 May; 46(5):1425-34. PubMed ID: 11959578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
    Treyaprasert W; Schmidt S; Rand KH; Suvanakoot U; Derendorf H
    Int J Antimicrob Agents; 2007 Mar; 29(3):263-70. PubMed ID: 17194570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia.
    Azoulay-Dupuis E; Vallée E; Bedos JP; Muffat-Joly M; Pocidalo JJ
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1024-8. PubMed ID: 1656849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.
    Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 1998 Apr; 41(4):451-9. PubMed ID: 9598776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin pharmacodynamics in four experimental pneumococcal infection models.
    Erlendsdottir H; Knudsen JD; Odenholt I; Cars O; Espersen F; Frimodt-Møller N; Fuursted K; Kristinsson KG; Gudmundsson S
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1078-85. PubMed ID: 11257018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic profiling of modithromycin: assessment in a pneumococcal murine pneumonia model.
    Maglio D; Sun HK; Patel T; Banevicius MA; Nightingale CH; Arya A; Wang G; Chen Z; Phan LT; Nicolau DP
    Int J Antimicrob Agents; 2014 Jun; 43(6):540-6. PubMed ID: 24703590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
    Veber B; Pocidalo JJ
    Pathol Biol (Paris); 1995 Jun; 43(6):524-8. PubMed ID: 8539075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
    Piroth L; Desbiolles N; Mateo-Ponce V; Martin L; Lequeu C; Charles PE; Portier H; Chavanet P
    J Antimicrob Chemother; 2001 Jan; 47(1):33-42. PubMed ID: 11152429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.
    Knudsen JD; Fuursted K; Raber S; Espersen F; Frimodt-Moller N
    Antimicrob Agents Chemother; 2000 May; 44(5):1247-54. PubMed ID: 10770759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.
    Knudsen JD; Fuursted K; Espersen F; Frimodt-Møller N
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1910-5. PubMed ID: 9303383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity and pharmacodynamics of azithromycin and clarithromycin against Streptococcus pneumoniae based on serum and intrapulmonary pharmacokinetics.
    Kays MB; Denys GA
    Clin Ther; 2001 Mar; 23(3):413-24. PubMed ID: 11318076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.